Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

26.04
Delayed Data
As of Mar 27
 +0.53 / +2.08%
Today’s Change
19.10
Today|||52-Week Range
47.65
+24.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.0048.5M158.4M
 
 
 
Cost of Goods Sold0.000.004.6M13.2M
 
 
 
Depreciation And Amortization45.2K197.0K469.0K1.2M
 
 
 
 
 
 
Operating ExpensesGross Income-45.2K-197.0K43.5M144.0M
 
 
 
 
 
General Expenses38.4M59.0M105.9M170.7M
 
 
 
 
 
Research And Development23.7M25.2M29.8M38.0M
 
 
 
 
 
Total Operating Expenses38.4M59.2M110.9M185.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.4M-59.2M-62.3M-26.7M
 
 
 
 
 
Extraordinary Charge-912.0K-1.4M-4.0K-5.0K
 
 
 
 
 
Interest Expense On Debt1.1M937.0K722.0K9.9M
 
 
 
 
 
Other Expenses747.8K-883.0K-211.0K-2.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.5M-62.3M-63.0M-38.5M
 
 
 
 
 
Income Taxes0.000.00-347.0K-899.0K
 
 
 
Net Income-39.5M-62.3M-63.4M-39.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.4M23.6M28.9M29.1M
 
 
 
 
 
Shares To Calculate EPS Diluted19.4M23.6M28.9M29.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.03-$2.64-$2.19-$1.35
 
 
 
 
 
EPS Diluted-$2.03-$2.64-$2.19-$1.35
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account